Influence
August 7, 2024

Impact of interhospital transfer on patients with Alzheimer’s disease and other related dementias

Kathleen Unroe, M.D.

Published in the journal Alzheimer’s and Dementia. Here is a link to the article.

Regenstrief Institute authors: Kathleen Unroe M.D., MHA, Malaz Boustani, M.D., MPH

This retrospective study examined the outcomes of interhospital transfers in older adults (≥65 years), comparing those with and without Alzheimer’s disease and related dementias (ADRD). Researchers reviewed medical records to assess care utilization and outcomes following emergency department transfers to tertiary hospitals.

Findings revealed that patients with ADRD were less likely to receive intensive care or undergo procedures within 48 hours of transfer (OR 1.87; 95% CI, 1.22–2.88). They were also less likely to be admitted as full code or discharged home. While they more frequently received geriatrics and palliative care consults, the benefit of transfer for this population remains unclear.

Overall, older adults with ADRD experienced fewer high-intensity interventions after transfer, raising questions about the value and appropriateness of such transfers. Further research is needed to evaluate patient-centered outcomes and guide care decisions for this vulnerable group.

Authors

Nancy Glober1, Alexandra LaShell1, Nicholas Montelauro1, Lindsay Troyer1, Michael Supples2, Kathleen Unroe1, Christopher Tainter3, Greg Faris1, Mikita Fuchita4, Malaz Boustani1

Author Affiliations

1Indiana University School of Medicine Indianapolis Indiana USA.

2Department of Emergency Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.

3University of California at San Diego La Jolla California USA.

4University of Colorado Hospital Aurora Colorado USA.

Related News

Reimagining real-world health data as essential public infrastructure

Reimagining real-world health data as essential public infrastructure

Researchers propose standards and community oversight to improve interoperability, accountability and public trust The U.S. healthcare system runs on

Arthur H. Owora, PhD

Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factors

Published in Annals of the American Thoracic Society. Here is a link to the article.  Regenstrief Institute author: Arthur H. Owora, PhD,

LOINC® advances global health interoperability with semiannual concept release

LOINC® version 2.82 introduces new terminology and technical enhancements to support global data exchange Regenstrief Institute launched the LOINC®

Inaugural pilot awards to advance nursing home clinical trials nationwide

Inaugural pilot awards to advance nursing home clinical trials nationwide

The National Institutes of Health’s (NIH) National Institute on Aging (NIA) awarded four pilot projects funded through NEXT STEPs